US Stock MarketDetailed Quotes

VERU Veru Inc

Watchlist

0.508
-0.039-7.20%

Close Mar 28 16:00 ET

0.509
+0.001+0.20%

Post 16:09 ET

74.38MMarket Cap-1.95P/E (TTM)

Veru Inc Stock Forum

Teddy123

Mar 5 21:31

Until Aug 25 to regain compliance

$Veru Inc (VERU.US)$
On February 27, 2025, the Company received a notification (the “Extension Notice”) from Nasdaq informing the Company that Nasdaq has granted the Company an additional 180 calendar days, or until August 25, 2025, to regain compliance with the minimum closing bid price requirement under the Rule for continued listing on Nasdaq. The Extension Notice has no immediate effect on the listing of the Company’s common stock. In connection with its reque...

Teddy123

Feb 21 22:10

Insider Purchase: Director at $VERU Buys 95,279 Shares

74419472

Feb 14 05:10

$Veru Inc (VERU.US)$ Why's this tanking?

JaYyYyYyY

Feb 13 23:40

$Veru Inc (VERU.US)$ why didnt rise~

This_Guy

Feb 13 19:43

$Veru Inc (VERU.US)$
taking a position here earning this morning

Trytosaveabit

Feb 13 19:38

Update! Other good stuff in report!

$Veru Inc (VERU.US)$ Veru (NASDAQ:VERU) reported quarterly losses of $(0.06) per share which beat the analyst consensus estimate of $(0.07) by 14.29 percent. This is a 25 percent increase over losses of $(0.08) per share from the same period last year.

Teddy123

Feb 13 19:32

Clinical research Analysis

$Veru Inc (VERU.US)$
The Phase 2b QUALITY study results represent a significant breakthrough in addressing a critical limitation of GLP-1 receptor agonists like Wegovy. The 71% reduction in lean mass loss and particularly the 99% preservation with the 3mg dose could position enobosarm as an essential companion therapy to GLP-1 drugs, especially for older adults where muscle preservation is crucial.
The body composition data is particularly compelling - while placebo + s...